Objective: Lung cancer screening (LCS) utilization remains low. We aimed at assessing LCS patient-reported barriers and preferred interventions to improve uptake.
Methods: Between July and November 2023, an electronic 60-item survey was completed by consented patients aged 50 to 80 years who were due to receive LCS, and their eligibility for LCS was confirmed.